[1]
Muñoz-Rangel, C.A., Fernandez-Vivar, E., Bañuelos-Gallo, R.A., Gonzalez-Ojeda, A., Macias-Amezcua, M.D., Chavez-Tostado, M., Ramirez-Campos, K.M., Ramirez-Arce, A. del R., Cortes-Lares, J.A. and Fuentes-Orozco, C. 2015. Minimally Invasive Therapy Using Intralesional OnabotulinumtoxinA in Peyronie’s Disease. Urology Journal. 12, 2 (Apr. 2015), 2105–2110. DOI:https://doi.org/10.22037/uj.v12i2.2894.